About the organization
Basic details : Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products.
At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Mission : Our mission is to discover new ways to improve and extend people's lives.
Vision : Our vision is to be a trusted leader in changing the practice of medicine.
Badges earned
People
Michaela Dinboeck
Senior Director Group Patient Advocacy & Communications
Basel, Switzerland
Nigel Cook
Driving patient focused initiatives within our patient access & drug development strategies
Basel, Switzerland
Initiatives
Co-creation of the Patient Engagement "Meta-Framework"
IMI HARMONY
Health Innovation Coalition – Health Crisis
Resources
Patient information leaflet on clinical trials - Clinical trials - of interest for you?
11 Feb 2019
WORKING TOGETHER GUIDE - A framework outlining how industry can engage with consumer groups
18 Mar 2019
Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies (Leaflet)
20 Mar 2019
The Economist Index of Cancer Preparedness
03 Apr 2019
Industry Representatives Release Call-To-Action On Patient Insight Compensation
31 May 2019
Digital Health from a Patient Perspective with recommendations on digital health
18 Oct 2019 Publication
Inaugural Roundtable Support Report
26 Feb 2020 Research report
European pharmaceutical industry response to COVID-19
30 Mar 2020 Article and blog post